کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1920425 | 1048695 | 2015 | 5 صفحه PDF | دانلود رایگان |
• A Peruvian family with early onset parkinsonism followed for more than 60 years.
• Two PARK2 mutations, in trans, a deletion of exon 7 and a point mutation in intron 5.
• Severe neuronal loss in the substantia nigra without Lewy bodies or other inclusions.
BackgroundMutations in PARK2 result in autosomal recessive young onset Parkinson's disease (YOPD). Although there have been a number of reports on the clinical characteristics of PARK2-related PD, there is limited information available on the associated neuropathologic changes.DesignWe describe the clinical and pathological characteristics of a Peruvian family with YOPD. The proband and one unaffected sibling were screened for PARK2 dosage and point mutations. One affected sibling had detailed neuropathologic examination.SettingInstituto Nacional de Ciencias Neurologicas (INCN) in Lima, Peru.ResultsThe proband and two of her four siblings developed YOPD and both parents were unaffected. The clinical course has been characterized by akinetic-rigid parkinsonism predominantly affecting the lower limbs and dyskinesias. Analysis of PARK2 showed that the proband is compound heterozygous for a novel acceptor splice site mutation in intron 5 (IVS5-1G>A) and an exon 7 deletion. Neuropathologic assessment of an affected sibling revealed severe neuronal loss in the substantia nigra (SN) and loss of tyrosine hydroxylase immunopositive fibers in the striatum. No Lewy body pathology was observed using standard histology or immunohistochemistry for α-synuclein.ConclusionsConsistent with most neuropathologic reports of patients with PARK2 mutations, we did not observe Lewy body inclusions, despite marked SN degeneration and severe dopaminergic denervation of the striatum. These data describe a novel splice site mutation and further extend the clinicopathological characterization of PARK2-associated PD.
Journal: Parkinsonism & Related Disorders - Volume 21, Issue 5, May 2015, Pages 444–448